Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary

BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI2) is a novel serum biomarker that discriminates ovarian clear cell carcinoma (CCC) from borderline ovarian tumors (BOTs) and non-clear cell epithelial ovarian cancers (EOCs). Here, we examined the performance of TFPI2 for preoperative diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyagi, Etsuko, Arakawa, Noriaki, Sakamaki, Kentaro, Yokota, Naho Ruiz, Yamanaka, Takeharu, Yamada, Yuki, Yamaguchi, Satoshi, Nagao, Shoji, Hirashima, Yasuyuki, Kasamatsu, Yuka, Kato, Hisamori, Mogami, Tae, Miyagi, Yohei, Kobayashi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213588/
https://www.ncbi.nlm.nih.gov/pubmed/34009487
http://dx.doi.org/10.1007/s10147-021-01914-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213588/
https://www.ncbi.nlm.nih.gov/pubmed/34009487
http://dx.doi.org/10.1007/s10147-021-01914-y

Ejemplares similares